doxycycline hyclate 200 MG Delayed Release Oral Tablet [Doryx]

RxCUI
1423082
RxNorm name
doxycycline hyclate 200 MG Delayed Release Oral Tablet [Doryx]
Display name
DORYX (Oral Pill)
Full name
doxycycline hyclate 200 MG Delayed Release Oral Tablet [Doryx]
Term type
SBD
Status
Active
Strength
200 mg
Dose form
DR Tab
Route
Oral Pill
Updated
2026-11-12 18:36:20

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062013
Active start
062013
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
doxycycline hyclate200 MG / 1 EACHdoxycyclinedoxycycline

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Delayed Release Oral Tablet10312

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
doxycycline3640

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRDoryx 200 MG Delayed Release Oral Tablet1NAMES
RxNorm Namedoxycycline hyclate 200 MG Delayed Release Oral Tablet [Doryx]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
RxCUI14230821CODES
MMSL_CODEBD287311CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 4 matching rows.

NDC11, Source, Active table
NDC11SourceActive
51862055806rxnav_ndcsyes
00430011420rxnav_historical
00430011495rxnav_historical
51862055800rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
99cf2de6-e0a3-42f2-9929-d33e107af948These highlights do not include all the information needed to use DORYX safely and effectively. See full prescribing information for DORYX. DORYX ® (doxycycline hyclate delayed-release tablets), for oral use. Initial U.S. Approval: 1967Mayne Pharma Commercial LLC | Mayne Pharma International Pty Ltd | Catalent Greenville, Inc.20250403

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4doxycycline
ATCJ01AATetracyclinesATC1-4doxycycline
FDASPLD013754TetracyclinesCHEMhas_chemical_structuredoxycycline
FDASPLN0000175882Tetracycline-class DrugEPChas_epcdoxycycline
MEDRTD004318DoxycyclineCHEMhas_ingredientdoxycycline hyclate
MEDRTD004318DoxycyclineCHEMhas_ingredientdoxycycline
MEDRTD013752TetracyclineCHEMci_chemclassdoxycycline
MEDRTD013752TetracyclineCHEMci_chemclassdoxycycline hyclate
MEDRTD000881AnthraxDISEASEmay_treatdoxycycline hyclate
MEDRTD000881AnthraxDISEASEmay_treatdoxycycline
MEDRTD002169Campylobacter InfectionsDISEASEmay_treatdoxycycline
MEDRTD002169Campylobacter InfectionsDISEASEmay_treatdoxycycline hyclate
MEDRTD002675Child, PreschoolDISEASEci_withdoxycycline hyclate
MEDRTD002675Child, PreschoolDISEASEci_withdoxycycline
MEDRTD002771CholeraDISEASEmay_treatdoxycycline hyclate
MEDRTD002771CholeraDISEASEmay_treatdoxycycline
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxycycline hyclate
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxycycline
MEDRTD006100Granuloma InguinaleDISEASEmay_treatdoxycycline
MEDRTD006100Granuloma InguinaleDISEASEmay_treatdoxycycline hyclate
MEDRTD008107Liver DiseasesDISEASEci_withdoxycycline hyclate
MEDRTD008107Liver DiseasesDISEASEci_withdoxycycline
MEDRTD008288MalariaDISEASEmay_preventdoxycycline
MEDRTD008288MalariaDISEASEmay_preventdoxycycline hyclate
MEDRTD009175Mycoplasma InfectionsDISEASEmay_treatdoxycycline
MEDRTD009175Mycoplasma InfectionsDISEASEmay_treatdoxycycline hyclate
MEDRTD010930PlagueDISEASEmay_treatdoxycycline
MEDRTD010930PlagueDISEASEmay_treatdoxycycline hyclate
MEDRTD010996Pleural EffusionDISEASEmay_treatdoxycycline hyclate
MEDRTD010996Pleural EffusionDISEASEmay_treatdoxycycline
MEDRTD018410Pneumonia, BacterialDISEASEmay_treatdoxycycline hyclate
MEDRTD018410Pneumonia, BacterialDISEASEmay_treatdoxycycline
MEDRTD011247PregnancyDISEASEci_withdoxycycline hyclate
MEDRTD011247PregnancyDISEASEci_withdoxycycline
MEDRTD009956PsittacosisDISEASEmay_treatdoxycycline hyclate
MEDRTD009956PsittacosisDISEASEmay_treatdoxycycline
MEDRTD012061Relapsing FeverDISEASEmay_treatdoxycycline hyclate
MEDRTD012061Relapsing FeverDISEASEmay_treatdoxycycline
MEDRTD012373Rocky Mountain Spotted FeverDISEASEmay_treatdoxycycline hyclate
MEDRTD012373Rocky Mountain Spotted FeverDISEASEmay_treatdoxycycline
MEDRTD012598SclerosisDISEASEinducesdoxycycline
MEDRTD012598SclerosisDISEASEinducesdoxycycline hyclate
MEDRTD013587SyphilisDISEASEmay_treatdoxycycline hyclate
MEDRTD013587SyphilisDISEASEmay_treatdoxycycline
MEDRTD014141TrachomaDISEASEmay_treatdoxycycline
MEDRTD014141TrachomaDISEASEmay_treatdoxycycline hyclate
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadoxycycline hyclate
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadoxycycline
MEDRTN0000008334Cell Membrane AlterationPEhas_pedoxycycline hyclate
MEDRTN0000008334Cell Membrane AlterationPEhas_pedoxycycline
MEDRTN0000008732Decreased MitosisPEhas_pedoxycycline hyclate
MEDRTN0000008732Decreased MitosisPEhas_pedoxycycline
MEDRTN0000008841Decreased Protein SynthesisPEhas_pedoxycycline hyclate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pedoxycycline

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH200 MG (expressed as doxycycline hyclate)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
NAMESPrescribable SynonymDORYX 200 MG Delayed Release Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMultum MediSource Lexicon